Insider Tracker SEC Form 4 insider trades
← All clusters
HCWB

HCW Biologics Inc.

AI summary Insiders buy shares in a private placement offering

64
Insider Score Band 60–79
Research score
71
AI adjustment
-7

Research score, not a recommendation.

Total bought$431.5K3 Form 4 purchases
Distinct insiders3open-market buyers
Lead insiderWong Hing CCEO
Cluster window2026-05-22single day · active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

same price, one day All 3 purchases were at $1.41 on 2026-05-22. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
37%
Seniority executive rank of buyers (CEO/CFO/Director)
91%
Commitment purchase size relative to company & holdings
90%
Context buying into stock weakness signals conviction
100%
Timing coordinated purchases within a tight window
100%
Routine-purchase discount × 1.00
Company-type / offering discount × 0.50
Net insider selling penalty − 0

Why are they buying?

AI · ipo_offering · catalyst explicit · documented

Insiders purchased shares directly from the company in a private placement offering priced at-the-market under Nasdaq rules alongside institutional healthcare investors.

On May 21, 2026, HCW Biologics announced the pricing of a private placement offering of units consisting of common stock (or pre-funded warrants) and warrants to raise approximately $4.0 million to fund clinical trials and general corporate purposes.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

3 Form 4 trades · 3 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Flags Filing
2026-05-22 GARRETT SCOTT T history of GARRETT SCOTT T's purchases Director 177,936 $1.41 $250.9K
offering
SEC filing for GARRETT SCOTT T (opens in a new tab)
2026-05-22 Wong Hing C 11 purchases with a 63-day result · median -21.0% CEO 113,879 $1.41 $160.6K
offering
SEC filing for Wong Hing C (opens in a new tab)
2026-05-22 Byam Rebecca 16 purchases with a 63-day result · median -16.1% CFO 14,235 $1.41 $20.1K
offering
SEC filing for Byam Rebecca (opens in a new tab)
Total $431.5K

Other buying runs at HCWB

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days -61.8%63 days -78.6%126 days –

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days63 days126 days Status
2026-07-29 3 $100.0K 56 +5.3%–– active
2025-05-16 3 $170.0K 64 -52.0%-73.7%-91.9% closed
2023-09-05 → 2023-09-14 3 $69.9K 46 -8.7%-53.6%-31.8% closed
2023-05-22 → 2023-06-09 4 $351.1K 57 +23.4%+10.3%-36.8% closed
2022-06-02 → 2022-06-14 4 $192.7K 58 +20.8%+15.8%-4.6% closed
2021-07-22 → 2021-08-31 6 $6.9M 65 -29.4%-57.7%-61.4% closed